Attention Deficit Hyperactivity Disorder
GPTKB entity
Statements (52)
Predicate | Object |
---|---|
gptkbp:instanceOf |
neurological disorder
|
gptkbp:abbreviation |
ADHD
|
gptkbp:affects |
adults
children |
gptkbp:associatedWith |
social problems
occupational impairment academic difficulties executive function deficits |
gptkbp:characterizedBy |
hyperactivity
impulsivity inattention |
gptkbp:commonMedication |
gptkb:atomoxetine
gptkb:methylphenidate amphetamine |
gptkbp:comorbidity |
gptkb:depression
gptkb:conduct_disorder gptkb:oppositional_defiant_disorder learning disabilities anxiety disorders |
gptkbp:controversy |
medication use
overdiagnosis |
gptkbp:diagnosedBy |
gptkb:DSM-5_criteria
clinical assessment behavioral observation |
gptkbp:DSM-5_code |
314.00
|
gptkbp:firstDescribed |
1902
|
gptkbp:gender |
more common in males
|
https://www.w3.org/2000/01/rdf-schema#label |
Attention Deficit Hyperactivity Disorder
|
gptkbp:ICD-10_code |
gptkb:F90
|
gptkbp:includedIn |
gptkb:DSM-5
gptkb:ICD-10 |
gptkbp:longTermOutcome |
may persist into adulthood
|
gptkbp:notableContributor |
gptkb:Sir_George_Frederic_Still
|
gptkbp:prevalence |
2.5% of adults worldwide
5% of children worldwide |
gptkbp:relatedTo |
ADD (Attention Deficit Disorder)
|
gptkbp:riskFactor |
genetics
premature birth prenatal exposure to tobacco prenatal exposure to alcohol |
gptkbp:subspecies |
combined presentation
predominantly hyperactive-impulsive predominantly inattentive |
gptkbp:supportersGroup |
gptkb:ADDA
CHADD |
gptkbp:symptomOnset |
before age 12
|
gptkbp:treatment |
gptkb:psychotherapy
behavioral therapy psychoeducation stimulant medication |
gptkbp:bfsParent |
gptkb:Attention_Deficit
|
gptkbp:bfsLayer |
5
|